NM_000435.3:c.4563A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000435.3(NOTCH3):​c.4563A>G​(p.Pro1521Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.893 in 1,595,316 control chromosomes in the GnomAD database, including 637,948 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.90 ( 62274 hom., cov: 34)
Exomes 𝑓: 0.89 ( 575674 hom. )

Consequence

NOTCH3
NM_000435.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -4.37

Publications

34 publications found
Variant links:
Genes affected
NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]
NOTCH3 Gene-Disease associations (from GenCC):
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral meningocele syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myofibromatosis, infantile, 2
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • pulmonary arterial hypertension
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 19-15174241-T-C is Benign according to our data. Variant chr19-15174241-T-C is described in ClinVar as Benign. ClinVar VariationId is 256138.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.37 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.969 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000435.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NOTCH3
NM_000435.3
MANE Select
c.4563A>Gp.Pro1521Pro
synonymous
Exon 25 of 33NP_000426.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NOTCH3
ENST00000263388.7
TSL:1 MANE Select
c.4563A>Gp.Pro1521Pro
synonymous
Exon 25 of 33ENSP00000263388.1

Frequencies

GnomAD3 genomes
AF:
0.902
AC:
137252
AN:
152178
Hom.:
62222
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.977
Gnomad AMI
AF:
0.885
Gnomad AMR
AF:
0.782
Gnomad ASJ
AF:
0.876
Gnomad EAS
AF:
0.805
Gnomad SAS
AF:
0.857
Gnomad FIN
AF:
0.883
Gnomad MID
AF:
0.886
Gnomad NFE
AF:
0.899
Gnomad OTH
AF:
0.879
GnomAD2 exomes
AF:
0.863
AC:
185645
AN:
215228
AF XY:
0.866
show subpopulations
Gnomad AFR exome
AF:
0.980
Gnomad AMR exome
AF:
0.718
Gnomad ASJ exome
AF:
0.872
Gnomad EAS exome
AF:
0.801
Gnomad FIN exome
AF:
0.886
Gnomad NFE exome
AF:
0.900
Gnomad OTH exome
AF:
0.860
GnomAD4 exome
AF:
0.892
AC:
1287588
AN:
1443020
Hom.:
575674
Cov.:
64
AF XY:
0.891
AC XY:
639275
AN XY:
717490
show subpopulations
African (AFR)
AF:
0.981
AC:
32499
AN:
33118
American (AMR)
AF:
0.724
AC:
30450
AN:
42038
Ashkenazi Jewish (ASJ)
AF:
0.871
AC:
22512
AN:
25858
East Asian (EAS)
AF:
0.827
AC:
32131
AN:
38862
South Asian (SAS)
AF:
0.859
AC:
73083
AN:
85068
European-Finnish (FIN)
AF:
0.886
AC:
41663
AN:
47036
Middle Eastern (MID)
AF:
0.846
AC:
4442
AN:
5250
European-Non Finnish (NFE)
AF:
0.903
AC:
998345
AN:
1106110
Other (OTH)
AF:
0.879
AC:
52463
AN:
59680
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
8111
16222
24332
32443
40554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21330
42660
63990
85320
106650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.902
AC:
137362
AN:
152296
Hom.:
62274
Cov.:
34
AF XY:
0.898
AC XY:
66849
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.977
AC:
40605
AN:
41578
American (AMR)
AF:
0.782
AC:
11955
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.876
AC:
3041
AN:
3472
East Asian (EAS)
AF:
0.805
AC:
4163
AN:
5170
South Asian (SAS)
AF:
0.857
AC:
4138
AN:
4830
European-Finnish (FIN)
AF:
0.883
AC:
9380
AN:
10620
Middle Eastern (MID)
AF:
0.878
AC:
258
AN:
294
European-Non Finnish (NFE)
AF:
0.899
AC:
61158
AN:
68018
Other (OTH)
AF:
0.880
AC:
1857
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
699
1398
2096
2795
3494
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.898
Hom.:
22666
Bravo
AF:
0.896
Asia WGS
AF:
0.854
AC:
2969
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 14, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29544907)

Nov 27, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lateral meningocele syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.15
DANN
Benign
0.67
PhyloP100
-4.4
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1044006; hg19: chr19-15285052; COSMIC: COSV54629991; COSMIC: COSV54629991; API